(Q28252396)

English

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial (English)

0 references

0 references

randomized experiment

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

3

object named as

Cyrille Hulin

0 references

Hervé Avet-Loiseau

27

object named as

Hervé Avet-Loiseau

0 references

Brigitte Pegourie

6

object named as

Brigitte Pegourie

0 references

Carine Chaleteix

10

object named as

Carine Chaleteix

0 references

Ibrahim Yakoub-Agha

object named as

Ibrahim Yakoub-Agha

25

0 references

1

object named as

Thierry Facon

0 references

author name string

Jean Yves Mary

2

0 references

Lotfi Benboubker

4

0 references

Michel Attal

5

0 references

Marc Renaud

7

0 references

Jean Luc Harousseau

8

0 references

Gaëlle Guillerm

9

0 references

Mamoun Dib

11

0 references

Laurent Voillat

12

0 references

Hervé Maisonneuve

13

0 references

Jacques Troncy

14

0 references

Véronique Dorvaux

15

0 references

Mathieu Monconduit

16

0 references

Claude Martin

17

0 references

Philippe Casassus

18

0 references

Jérôme Jaubert

19

0 references

Henry Jardel

20

0 references

Chantal Doyen

21

0 references

Brigitte Kolb

22

0 references

Bruno Anglaret

23

0 references

Bernard Grosbois

24

0 references

Claire Mathiot

26

0 references

language of work or name

0 references

publication date

6 October 2007

0 references

0 references

370

0 references

9594

0 references

1209-18

0 references

randomized experiment

0 references

Multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide and hematopoietic-cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Maintenance therapy with thalidomide improves survival in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

International staging system for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961537-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61537-2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28252396&oldid=1620760231"